Gottlieb: Brand Industry 'Gaming' Tactics Have Shifted
Former FDA Commissioner Sees Shift From Regulatory To Commercial Space
US FDA's focus on areas such as REMS abuse may have prompted certain brand sponsors to shift their focus to the commercial space to keep generic competition off the market, former commissioner Scott Gottlieb tells the Association for Accessible Medicines.
